Koyfin Home > Directory > Financials > CME Group Inc > EBITDA

CME Group Inc EBITDA Chart (CME)

CME Group Inc annual/quarterly EBITDA from 2010 to 2020. EBITDA stands for earnings before interest, taxes, depreciation and amortization. EBITDA is one indicator of a company's financial performance and is used as a proxy for the earning potential of a business, although doing so can have drawbacks. EBITDA strips out the cost of debt capital and its tax effects by adding back interest and taxes to earnings.
  • CME Group Inc EBITDA for the quarter ending June 06, 2020 was $751m a -7.41% decrease of -56m year over year
  • CME Group Inc EBITDA for the last 12 months ending June 06, 2020 was $3,388m a 6.18% increase of 209m year over year
  • CME Group Inc Annual EBITDA for 2019 was $3,129m a 6.38% increase of 200m from 2018
  • CME Group Inc Annual EBITDA for 2018 was $2,930m a 14.34% increase of 420m from 2017
  • CME Group Inc Annual EBITDA for 2017 was $2,510m a 2.45% increase of 62m from 2016
Other Income Statement Metrics:
  • CME Group Inc Net Income for the quarter ending December 12, 2018 was $386m a -55.33% decrease of -213m year over year
  • CME Group Inc Total Revenue for the quarter ending December 12, 2018 was $1,237m a 10.32% increase of 128m year over year
View Chart On Koyfin

Quarterly CME EBITDA Data

06/2020$751m
03/2020$1,073m
12/2019$757m
09/2019$806m
06/2019$821m
03/2019$745m
12/2018$815m
09/2018$604m
06/2018$718m
03/2018$793m

Annual CME EBITDA Data

2019$3,129m
2018$2,930m
2017$2,510m
2016$2,448m
2015$2,229m
2014$2,017m
2013$1,892m
2012$1,945m
2011$2,272m
2010$2,110m